Related content

Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects

By Kohn Y.   Ebstein R.P.   Heresco-Levy U.   Shapira B.   Nemanov L.   Gritsenko I.   Avnon M.   Lerer B.  

European Neuropsychopharmacology, Vol. 7, Iss. 1, 1997-02 ,pp. : 39-43

Elsevier

Access to resources Recommend Favorite

Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorphisms

By Güzey Cüneyt   Scordo Maria   Spina Edoardo   Landsem Veslemøy   Spigset Olav  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 3, 2007-03 ,pp. : 233-241

Springer Publishing Company

Access to resources Recommend Favorite

Sexual dysfunction in male schizophrenia: influence of antipsychotic drugs, prolactin and polymorphisms of the dopamine D2 receptor genes

By Zhang Xiang Rong   Zhang Zhi Jun   Zhu Rong Xin   Yuan Yong Gui   Jenkins Trisha A   Reynolds Gavin P  

Pharmacogenomics, Vol. 12, Iss. 8, 2011-08 ,pp. : 1127-1136

Future Medicine

Access to resources Recommend Favorite

Behavioral response profiles following drug challenge with dopamine receptor subtype agonists and antagonists in developing rat

By Sobrian S.K.   Jones B.L.   Varghese S.   Holson R.R.  

Neurotoxicology and Teratology, Vol. 25, Iss. 3, 2003-05 ,pp. : 311-328

Elsevier

Access to resources Recommend Favorite

Investigational drugs for schizophrenia targeting the dopamine receptor: Phase II trials

By Rao Naren P   Remington Gary  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 7, 2013-11 ,pp. : 881-894

Informa Healthcare

Access to resources Recommend Favorite